These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 24418373

  • 21. Prevalence of myocardial infarction is related to hyperhomocysteinemia but not influenced by C677T methylenetetrahydrofolate reductase and A2756G methionine synthase polymorphisms in diabetic and non-diabetic subjects.
    Helfenstein T, Fonseca FA, Relvas WG, Santos AO, Dabela ML, Matheus SC, D'Almeida V, Tufik S, Souza FG, Rodrigues PR, Taglieri R, Sousa EF, Izar MC.
    Clin Chim Acta; 2005 May; 355(1-2):165-72. PubMed ID: 15820491
    [Abstract] [Full Text] [Related]

  • 22. Plasma homocysteine levels & 677C-->T methylenetetrahydrofolate reductase gene polymorphism in patients with coronary artery disease of different severity.
    Rassoul F, Richter V, Hentschel B, Geisel J, Herrmann W, Kuntze T.
    Indian J Med Res; 2008 Feb; 127(2):154-8. PubMed ID: 18403793
    [Abstract] [Full Text] [Related]

  • 23. Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients.
    Adinolfi LE, Ingrosso D, Cesaro G, Cimmino A, D'Antò M, Capasso R, Zappia V, Ruggiero G.
    Hepatology; 2005 May; 41(5):995-1003. PubMed ID: 15834927
    [Abstract] [Full Text] [Related]

  • 24. Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous coronary intervention in patients with stable and unstable coronary artery disease (from the JUMBO-TIMI 26 trial).
    Bonaca MP, Wiviott SD, Sabatine MS, Buros J, Murphy SA, Scirica BM, Rifai N, Antman EM, Morrow DA.
    Am J Cardiol; 2007 Feb 01; 99(3):344-8. PubMed ID: 17261395
    [Abstract] [Full Text] [Related]

  • 25. Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients.
    Verdoia M, Schaffer A, Barbieri L, Di Giovine G, Marino P, Suryapranata H, De Luca G, Novara Atherosclerosis Study Group (NAS).
    J Diabetes Complications; 2015 Feb 01; 29(4):517-22. PubMed ID: 25736187
    [Abstract] [Full Text] [Related]

  • 26. The MTHFR 677 C/T polymorphism influences plasma levels of adhesion molecules and nitric oxide.
    Juo SH, Liao YC, Kuo CL, Wang Y, Huang CS, Chiang HC, Liu CS.
    Thromb Res; 2008 Feb 01; 121(4):549-54. PubMed ID: 17707074
    [Abstract] [Full Text] [Related]

  • 27. Uric acid and risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention.
    Verdoia M, Schaffer A, Barbieri L, Di Giovine G, Marino P, De Luca G, Novara Atherosclerosis Study Group (NAS).
    Diabetes Metab Res Rev; 2014 May 01; 30(4):297-304. PubMed ID: 24829966
    [Abstract] [Full Text] [Related]

  • 28. C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients.
    Gemmati D, Serino ML, Trivellato C, Fiorini S, Scapoli GL.
    Haematologica; 1999 Sep 01; 84(9):824-8. PubMed ID: 10477457
    [Abstract] [Full Text] [Related]

  • 29. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and variations of homocysteine concentrations in patients with Behcet's disease.
    Messedi M, Frigui M, Chaabouni Kh, Turki M, Neifer M, Lahiyani A, Messaouad M, Bahloul Z, Ayedi F, Jamoussi K.
    Gene; 2013 Sep 15; 527(1):306-10. PubMed ID: 23827456
    [Abstract] [Full Text] [Related]

  • 30. No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study.
    Bezemer ID, Doggen CJ, Vos HL, Rosendaal FR.
    Arch Intern Med; 2007 Mar 12; 167(5):497-501. PubMed ID: 17353498
    [Abstract] [Full Text] [Related]

  • 31. Evaluation of troponin T criteria for periprocedural myocardial infarction in patients with acute coronary syndromes.
    Shugman IM, Diu P, Gohil J, Kadappu KK, Leung M, Lo S, Leung DY, Hopkins AP, Juergens CP, French JK.
    Am J Cardiol; 2011 Mar 15; 107(6):863-70. PubMed ID: 21376928
    [Abstract] [Full Text] [Related]

  • 32. Higher incidence of C677T polymorphism of the MTHFR gene in North Indian patients with vascular disease.
    Bhargava S, Ali A, Parakh R, Saxena R, Srivastava LM.
    Vascular; 2012 Apr 15; 20(2):88-95. PubMed ID: 22375042
    [Abstract] [Full Text] [Related]

  • 33. [Effect of polymorphisms on key enzymes in homocysteine metabolism, on plasma homocysteine level and on coronary artery-disease risk in a Tunisian population].
    Belkahla R, Omezzine A, Kchok K, Rebhi L, Ben Hadj Mbarek I, Rejeb J, Ben Rejeb N, Slimane N, Nabli N, Ben Abdelaziz A, Boughzala E, Bouslama A.
    Ann Cardiol Angeiol (Paris); 2008 Aug 15; 57(4):219-24. PubMed ID: 18620331
    [Abstract] [Full Text] [Related]

  • 34. Association of baseline C-reactive protein levels with periprocedural myocardial injury in patients undergoing percutaneous bifurcation intervention: a CACTUS study subanalysis.
    Niccoli G, Sgueglia GA, Latib A, Crea F, Colombo A, CACTUS Study Group.
    Catheter Cardiovasc Interv; 2014 Jan 01; 83(1):E37-44. PubMed ID: 23813627
    [Abstract] [Full Text] [Related]

  • 35. Homocysteine status and polymorphisms of methylenetetrahydrofolate reductase are not associated with restenosis after stenting in coronary arteries.
    Koch W, Ndrepepa G, Mehilli J, Braun S, Burghartz M, Lengnick H, Kölling K, Schömig A, Kastrati A.
    Arterioscler Thromb Vasc Biol; 2003 Dec 01; 23(12):2229-34. PubMed ID: 14604831
    [Abstract] [Full Text] [Related]

  • 36. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction.
    Hassan A, Hunt BJ, O'Sullivan M, Bell R, D'Souza R, Jeffery S, Bamford JM, Markus HS.
    Brain; 2004 Jan 01; 127(Pt 1):212-9. PubMed ID: 14607791
    [Abstract] [Full Text] [Related]

  • 37. Protective effect against alcohol dependence of the thermolabile variant of MTHFR.
    Saffroy R, Benyamina A, Pham P, Marill C, Karila L, Reffas M, Debuire B, Reynaud M, Lemoine A.
    Drug Alcohol Depend; 2008 Jul 01; 96(1-2):30-6. PubMed ID: 18328637
    [Abstract] [Full Text] [Related]

  • 38. C677T mutation of methylenetetrahydrofolate reductase gene and serum homocysteine levels in Turkish patients with coronary artery disease.
    Yilmaz H, Isbir S, Agachan B, Ergen A, Farsak B, Isbir T.
    Cell Biochem Funct; 2006 Jul 01; 24(1):87-90. PubMed ID: 15648053
    [Abstract] [Full Text] [Related]

  • 39. Prognostic impact of periprocedural bleeding and myocardial infarction after percutaneous coronary intervention in unselected patients: results from the EVENT (evaluation of drug-eluting stents and ischemic events) registry.
    Lindsey JB, Marso SP, Pencina M, Stolker JM, Kennedy KF, Rihal C, Barsness G, Piana RN, Goldberg SL, Cutlip DE, Kleiman NS, Cohen DJ, EVENT Registry Investigators.
    JACC Cardiovasc Interv; 2009 Nov 01; 2(11):1074-82. PubMed ID: 19926047
    [Abstract] [Full Text] [Related]

  • 40. The MTHFR CT polymorphism confers a high risk for stroke in both homozygous and heterozygous T allele carriers with Type 2 diabetes.
    Hermans MP, Gala JL, Buysschaert M.
    Diabet Med; 2006 May 01; 23(5):529-36. PubMed ID: 16681562
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.